Patients who did not receive EGFR TKIs had a significantly higher risk of dying or needing subsequent treatment.
All articles by John Schieszer
A systematic review revealed characteristics that may help clinicians predict which patients will benefit from immunotherapy.
An overview of the role of statins in reducing in-hospital deaths due to COVID-19, using findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry.
In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”